Literature DB >> 25464119

Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.

Junya Kanda1, Tatsuo Ichinohe2, Shigeo Fuji3, Yoshinobu Maeda4, Kazuteru Ohashi5, Takahiro Fukuda3, Koichi Miyamura6, Koji Iwato7, Tetsuya Eto8, Hirohisa Nakamae9, Naoki Kobayashi10, Takehiko Mori11, Shin-Ichiro Mori12, Yasuo Morishima13, Yoshiko Atsuta14, Yoshinobu Kanda15.   

Abstract

The relative desirability of an unrelated donor with a bidirectional 1-locus mismatch (1MM-Bi), a 1-locus mismatch only in the graft-versus-host direction (1MM-GVH), or a 1-locus mismatch only in the host-versus-graft direction (1MM-HVG) is not yet clear. We analyzed adult patients with leukemia or myelodysplastic syndrome who received a first allogeneic stem cell transplant from an HLA-A, -B, -C, and -DRB1 matched or 1-allele mismatched unrelated donor in Japan. The effects of 1MM-Bi (n = 1020), 1MM-GVH (n = 83), and 1MM-HVG (n = 83) compared with a zero mismatch (0MM) (n = 2570) were analyzed after adjusting for other significant variables. The risk of grades III to IV acute graft-versus-host disease (GVHD) was higher with marginal significance in the 1MM-GVH group than in the 0MM group (hazard ratio, 1.85; P = .014). However, there was no significant difference in overall or nonrelapse mortality between the 1MM-GVH and 0MM groups. There was no significant difference in acute GVHD or overall or nonrelapse mortality between the 1MM-HVG and 0MM groups. The risks of acute GVHD and overall mortality were significantly higher in the 1MM-Bi group than in the 0MM group. These findings indicate that unrelated donors with 1MM-GVH and 1MM-HVG are both good candidates for patients without an HLA-matched unrelated donor in a Japanese cohort.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Donor selection; GVHD; Graft-versus-host direction; HLA mismatch; Host-versus-graft direction; Overall survival

Mesh:

Substances:

Year:  2014        PMID: 25464119     DOI: 10.1016/j.bbmt.2014.10.015

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  10 in total

1.  Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation.

Authors:  Junya Kanda
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.

Authors:  K Kawamura; J Kanda; S Fuji; M Murata; K Ikegame; K Yoshioka; T Fukuda; Y Ozawa; N Uchida; K Iwato; T Sakura; M Hidaka; H Hashimoto; T Ichinohe; Y Atsuta; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

3.  Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.

Authors:  Junya Kanda; Katsutsugu Umeda; Koji Kato; Makoto Murata; Junichi Sugita; Souichi Adachi; Katsuyoshi Koh; Maiko Noguchi; Hiroaki Goto; Nao Yoshida; Maho Sato; Yuhki Koga; Tsukasa Hori; Yuko Cho; Atsushi Ogawa; Masami Inoue; Yoshiko Hashii; Yoshiko Atsuta; Takanori Teshima
Journal:  Bone Marrow Transplant       Date:  2020-03-11       Impact factor: 5.483

4.  Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.

Authors:  K Fleischhauer; K W Ahn; H L Wang; L Zito; P Crivello; C Müller; M Verneris; B E Shaw; J Pidala; M Oudshorn; S J Lee; S R Spellman
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

Review 5.  Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results.

Authors:  Hany Elmariah; Ephraim J Fuchs
Journal:  Semin Hematol       Date:  2018-09-20       Impact factor: 3.754

Review 6.  Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Authors:  Mateja Kralj Juric; Sakhila Ghimire; Justyna Ogonek; Eva M Weissinger; Ernst Holler; Jon J van Rood; Machteld Oudshoorn; Anne Dickinson; Hildegard T Greinix
Journal:  Front Immunol       Date:  2016-11-09       Impact factor: 7.561

Review 7.  Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis.

Authors:  Ruxiu Tie; Tiansong Zhang; Bo Yang; Huarui Fu; Biqing Han; Jian Yu; Yamin Tan; He Huang
Journal:  Oncotarget       Date:  2017-04-18

8.  Durable outcomes of double cord blood transplantation in adults with acute lymphoblastic leukemia: high-risk features for early and long-term mortality.

Authors:  Jae-Ho Yoon; Gi June Min; Sung-Soo Park; Silvia Park; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Jong Wook Lee; Seok Lee
Journal:  Ther Adv Hematol       Date:  2022-02-16

9.  Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation.

Authors:  Makoto Iwasaki; Junya Kanda; Hidenori Tanaka; Takero Shindo; Takahiko Sato; Noriko Doki; Takahiro Fukuda; Yukiyasu Ozawa; Tetsuya Eto; Naoyuki Uchida; Yuta Katayama; Keisuke Kataoka; Takahide Ara; Shuichi Ota; Makoto Onizuka; Yoshinobu Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Satoko Morishima
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561

10.  HLA Diversity in Saudi Population: High Frequency of Homozygous HLA Alleles and Haplotypes.

Authors:  Aziz Alami Chentoufi; F Aytül Uyar; Hiba A Chentoufi; Khalid Alzahrani; Maria Paz; Ahmed Bahnassy; Ghaleb Elyamany; Assem Elghazaly
Journal:  Front Genet       Date:  2022-06-09       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.